Flavan enantiomers from Daphne giraldii selectively induce apoptotic cell death in p53-null hepatocarcinoma cells in vitro
Guo-Dong Yao1, Qian Sun2, Xiao-Yu Song1
1Department of Natural Products Chemistry, Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China.
Abstract:
Hepatocellular carcinoma (HCC) is a primary malignant tumor with very poor prognosis. To search for more effective compounds for HCC treatment, two new pairs of flavan enantiomers, daphnegiranol C1/C2 (1a/1b) and daphnegiranol D1/D2 (2a/2b), were isolated from the stem bark and roots of Daphne giraldii by using chiral chromatography. MTT assay was applied to evaluate their cytotoxicity against three hepatocarcinoma cell lines (Hep3B, MHCC97H, HepG2) as well as a normal liver cell line L02. The results showed that these compounds preferred to inhibit the growth of Hep3B cells (p53 null). Among them, 2a/2b (the IC50 value was 4.87 and 3.35 μM, respectively) exhibited a stronger cytotoxic effect than sorafenib (IC50 = 6.59 μM) in Hep3B cells. A further study demonstrated that 2a/2b could induce apoptotic cell death with an increase in reactive oxygen species (ROS) in Hep3B cells. In addition, the IC50 values of 2a/2b in HepG2 and MHCC97H cells (both harbored p53 gene) were more than 10-folds greater when compared with Hep3B cells, indicating that 2a/2b selectively exhibited cytotoxicity in p53-null hepatocarcinoma cells. Moreover, inhibition of p53 increased the inhibitory effect in p53-wild hepatocarcinoma cells, as well as apoptotic cells and ROS generation. Taken together, flavan enantiomers 2a/2b selectively induced apoptosis in Hep3B cells because of p53 deficiency.
Insights
New flavan enantiomers selectively target hepatocellular carcinoma (HCC) cells lacking the p53 gene. These compounds, daphnegiranol D1/D2, show potent cytotoxicity and induce apoptosis, offering a promising avenue for HCC treatment strategies.
Area of Science:
- Natural Products Chemistry
- Pharmacology
- Oncology
Background:
- Hepatocellular carcinoma (HCC) presents a significant therapeutic challenge due to its poor prognosis.
- Identifying novel compounds with potent anticancer activity is crucial for advancing HCC treatment.
Purpose of the Study:
- To isolate and characterize new flavan enantiomers from Daphne giraldii.
- To evaluate the cytotoxic effects of these compounds on various hepatocarcinoma cell lines.
- To elucidate the mechanism of action, particularly concerning the role of p53.
Main Methods:
- Chiral chromatography for isolation of flavan enantiomers.
- MTT assay for cytotoxicity evaluation against Hep3B, MHCC97H, HepG2, and L02 cell lines.
- Analysis of apoptosis induction and reactive oxygen species (ROS) generation.
Main Results:
- Two pairs of flavan enantiomers, daphnegiranols C1/C2 (1a/1b) and D1/D2 (2a/2b), were isolated.
- Compounds 2a/2b demonstrated significant cytotoxicity against p53-null Hep3B cells, outperforming sorafenib.
- Cytotoxicity was selective for p53-null cells, with p53-wild cells showing >10-fold higher IC50 values.
- Compounds 2a/2b induced apoptosis and increased ROS generation in Hep3B cells.
Conclusions:
- Flavan enantiomers 2a/2b exhibit selective cytotoxicity towards p53-deficient hepatocellular carcinoma cells.
- These compounds induce apoptosis and ROS generation, suggesting a targeted therapeutic potential.
- The p53 status of cancer cells is a critical factor in their sensitivity to these novel flavan enantiomers.
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Naming Enantiomers
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Induced Pluripotent Stem Cells


